The present invention comprises a new class of compounds capable of modulating the c-kit receptor and, accordingly, useful for treatment of c-kit mediated diseases, including various fibrotic and mast cell related diseases such as mastocytosis. The compounds have a general Formula I
wherein R
1-6
, X and Y are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of c-kit mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
本发明涉及一类新的化合物,能够调节c-kit受体,因此可用于治疗c-kit介导的疾病,包括各种纤维化和肥大
细胞相关疾病,如肥大细胞增多症。该化合物具有通用的I式,其中R1-6、X和Y在此定义。本发明还包括制药组合物、治疗c-kit介导疾病的方法,以及制备本发明化合物的中间体和方法。